2025 annual financial data
Cartesian Therapeutics 2025 Operating margin
Cartesian Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -3,099.93%.
Operating income was -86,705,000 USD and net income was -130,302,000 USD.
Operating cash flow was -73,941,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,797,000 USD
- Operating income
- -86,705,000 USD
- Net income
- -130,302,000 USD
- Operating cash flow
- -73,941,000 USD